The incidence of drug-resistant forms of tuberculosis (DR-TB) and the number of children treated with second-line drugs (SLDs) are increasing. However, limited amount of information is available regarding the use of SLDs in this population.

Use of Second-line Medications and Treatment Outcomes in Children With Tuberculosis in a Single Center From 2007 to 2018 / Chiappini, Elena; Matucci, Tommaso; Lisi, Catiuscia; Petrolini, Chiara; Venturini, Elisabetta; Tersigni, Chiara; de Martino, Maurizio; Galli, Luisa. - In: THE PEDIATRIC INFECTIOUS DISEASE JOURNAL. - ISSN 1532-0987. - STAMPA. - 38:(2019), pp. 1027-1034. [10.1097/INF.0000000000002410]

Use of Second-line Medications and Treatment Outcomes in Children With Tuberculosis in a Single Center From 2007 to 2018

Chiappini, Elena
;Petrolini, Chiara;Venturini, Elisabetta;Tersigni, Chiara;de Martino, Maurizio;Galli, Luisa
2019

Abstract

The incidence of drug-resistant forms of tuberculosis (DR-TB) and the number of children treated with second-line drugs (SLDs) are increasing. However, limited amount of information is available regarding the use of SLDs in this population.
2019
38
1027
1034
Chiappini, Elena; Matucci, Tommaso; Lisi, Catiuscia; Petrolini, Chiara; Venturini, Elisabetta; Tersigni, Chiara; de Martino, Maurizio; Galli, Luisa...espandi
1a - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1173232
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact